ALOGLIPTIN (Nesina) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

ALOGLIPTIN

What is the Trade Name for ALOGLIPTIN

Nesina

What is the Indication for ALOGLIPTIN

  • 1 INDICATIONS AND USAGE NESINA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14) ]. NESINA is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1. ) Limitations of Use: Should not be used in patients with type 1 diabetes. ( 1 ) Limitations of Use NESINA should not be used in patients with type 1 diabetes mellitus.

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]